Joshua A. Kazam - Jun 10, 2021 Form 4 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role
Director
Signature
/s/ Veer Bhavnagri, Attorney-in-Fact
Stock symbol
ALLO
Transactions as of
Jun 10, 2021
Transactions value $
$0
Form type
4
Date filed
6/11/2021, 05:43 PM
Previous filing
Jun 7, 2021
Next filing
Jun 23, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALLO Common Stock Award $0 +16.5K +2.27% $0.00 744K Jun 10, 2021 Direct
transaction ALLO Common Stock Gift $0 -500K -67.21% $0.00 244K Jun 11, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 11, 2021, the reporting person transferred 500,000 shares of common stock to an irrevocable grantor trust having an independent trustee. The reporting person disclaims beneficial ownership of these shares except to the extent, if any, of the reporting person's pecuniary interest therein.